News Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Real-time Estimate Cboe Europe Other stock markets 05:49:56 2024-04-26 am EDT			5-day change	1st Jan Change
873.4 ^DKK	+0.76%		+0.69%	+24.94%

Apr. 25	NOVO NORDISK : JP Morgan gives a Buy rating	ZD
Apr. 25	Scholz promises support for pharma sector in Germany as Merck invests	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nonalcoholic Steatohepatitis Market to Observe Impressive Growth During the Forecast Period \| Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals	04:20am	AQ
NOVO NORDISK : JP Morgan gives a Buy rating	Apr. 25	ZD
Scholz promises support for pharma sector in Germany as Merck invests	Apr. 25	RE
Sector Update: Health Care Stocks Slipping Late Afternoon	Apr. 24	MT
Sector Update: Health Care	Apr. 24	MT
Novo Nordisk's Wegovy FDA Approval for Heart Health Opens Door to Medicare Access, KKF Says	Apr. 24	MT
US Senate committee investigates pricing of Novo's Ozempic and Wegovy	Apr. 24	RE
Novo Nordisk Probed by Senate Committee on Weight-Loss Drug Prices	Apr. 24	DJ
Novo Nordisk A/S : Reduction of the share capital	Apr. 24	PU
Novo Nordisk A/S - Articles of Association, April 2024	Apr. 24	GL
Novo Nordisk A/S – Reduction of the share capital	Apr. 24	GL
NOVO NORDISK : Bernstein maintains a Buy rating	Apr. 24	ZD
Germany's Evotec appoints Christian Wojczewski as CEO	Apr. 23	RE
UK stocks may finally be back in fashion	Apr. 23	RE
Health Care Climbs on Earnings Hopes -- Health Care Roundup	Apr. 22	DJ
Eli Lilly to acquire manufacturing facility from Nexus Pharma	Apr. 22	RE
Novo Nordisk A/S - share repurchase programme	Apr. 22	GL
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut	Apr. 21	AQ
India's Biocon developing its own version of Wegovy, clinical trial likely next year	Apr. 18	RE
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	Apr. 15	GL